Nurix Therapeutics to Present at the Targeted Protein Degradation Summit 2019
October 15, 2019 09:30 ET
|
Nurix
SAN FRANCISCO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that Arthur Sands, M.D., Ph.D., chief...
Nurix Therapeutics Announces Key Additions to its Board of Directors
October 08, 2019 09:32 ET
|
Nurix
SAN FRANCISCO, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s natural process to control protein levels, today announced Lori A....
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
June 19, 2019 08:30 ET
|
Nurix; Gilead Sciences, Inc.
FOSTER CITY, Calif. and SAN FRANCISCO, June 19, 2019 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s...
Nurix Therapeutics to Present at the Needham & Company 18th Annual Healthcare Conference
April 04, 2019 08:00 ET
|
Nurix
SAN FRANCISCO, April 04, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced...
Nurix Therapeutics to Present at 2019 American Association for Cancer Research (AACR) Annual Meeting
March 19, 2019 08:00 ET
|
Nurix
SAN FRANCISCO, March 19, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced an...
Nurix Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 21, 2018 14:00 ET
|
Nurix
SAN FRANCISCO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
Nurix Therapeutics to Present at the Stifel Healthcare Conference
November 07, 2018 09:00 ET
|
Nurix
SAN FRANCISCO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
Nurix Therapeutics to Present at the Targeted Protein Degradation Summit 2018
October 17, 2018 08:00 ET
|
Nurix
SAN FRANCISCO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
Nurix Therapeutics to Present at the 2018 BIO Investor Forum
October 10, 2018 08:00 ET
|
Nurix
SAN FRANCISCO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
Nurix Appoints Nancy Pryer, Ph.D., Chief Development Officer
May 08, 2018 08:00 ET
|
Nurix
SAN FRANCISCO, May 08, 2018 (GLOBE NEWSWIRE) -- Nurix, Inc., a private drug discovery company, today announced the appointment of Dr. Nancy Pryer as the company’s chief development officer. Dr....